The interaction between chronic low-level lead and the Amyloid Β Precursor Protein

Amyloid

Volumn 5, Issue 2, 1998, Pages 90-98

  Davey, Fleur D ^a   Breen, Kieran C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adhesion; Alzheimer's disease; Amyloid; Development; Lead; Neurotoxicity

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DIVALENT CATION;

ANIMAL; ARTICLE; CELL LINE; CHRONIC DISEASE; LEAD POISONING; METABOLISM; MOUSE; STATISTICAL MODEL;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CATIONS, DIVALENT; CELL LINE; CHRONIC DISEASE; LEAD POISONING; LOGISTIC MODELS; MICE;

EID: 0032085219     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129808995286     Document Type: Article

References (38)

1. Kang J, Lemaire H, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K, Multhaup G, Beyreuther K and Muller-Hill B (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736
2. Breen KC, Coughlan CM and Hayes FD (1998). The role of glycoproteins in neural development, function and disease. Mol Neurobiol 16, 1-59
3. Clarris HJ, Cappai R, Heffernan D, Beyreuther K, Masters CL and Small DH (1997). Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer's disease by deletion mutagenesis and peptide mapping. J Neurochem 68, 1164-1172
4. Breen KC (1992). APP-collagen interaction is mediated by a heparin bridge mechanism. Mol Chem Neuropathol 16, 109-121
5. Small DH, Nurcombe V, Reed G, Clarris H, Moir R, Beyreuther K and Masters CL (1994). A heparin-binding domain in the amyloid protein-precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 14, 2117-2127
6. Moya KL, Benowitz LI, Schneider GE and Allinquant B (1994). The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev Biol 161, 597-603
7. Doyle E, Bruce MT, Breen KC, Smith DC, Anderton BH and Regan CM (1990). Intraventricular infusions of antibodies to amyloid-β-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci Lett 115, 97-102
8. Fazeli MS, Breen KC, Errington ML and Bliss TVP (1994). Increase in extracellular NCAM and amyloid precursor protein following induction of long-term potentiation in the dentate gyrus of anaesthetized rats. Neurosci Lett 169, 77-80
9. Hesse L, Beher D, Masters CL and Multhaup G (1994). The βA4 amyloid precursor protein binding to copper. FEBS Lett 349, 109-116
10. Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL and Beyreuther K (1996). The amyloid precursor protein of Alzheimer's disease in the reduction of Cu(II) to Cu(I). Science 271, 1406-1409
11. Bush AI, Pettingell WH, Paradis MD and Tanzi RE (1994). Modulation of Aβ adhesiveness and secretase site cleavage by zinc. J Biol Chem 269, 12152-12158
12. Mattson MP (1994). Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocamal neurons. J Neurobiol 25, 439-450
13. Smithswintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE and Mattson MP (1994). Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J Neurochem 63, 781-784
14. Goodman Y and Mattson MP (1994). Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp Neurol 128, 1-12
15. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG and Cotman CW (1993). Neurodegeneration induced by beta amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13, 1676-1687
16. Haring R, Gurwitz D, Barg J, Pinkaskramarski R, Heldman E, Pittel Z, Danberg HD, Wengier A, Meshulam H, Marciano D, Karton Y and Fisher A (1995). NGF promotes amyloid precursor protein secretion via muscarinic receptor activation. Biochem Biophys Res Comm 213, 15-23
17. Goldstein GW (1990). Lead poisoning and brain cell function. Environ Health Perspect 89, 91-94
18. Bellinger D, Leviton A, Waternaux C, Needleman H and Rabinowitz M (1987). Longitudinal analysis of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 316, 1037-1043
19. Fjerdingstad EJ, Danscher G and Fjerdingstad E (1974). Hippocampus: selective concentration of laed in the normal rat brain. Brain Res 80, 350-354
20. Clarkson TW (1993). Molecular and ionic mimicry of toxic metals. Annu Rev Pharmacol Toxicol 32, 545-571
21. Kostial K and Vouk VB (1957). Lead ions and synaptic transmission in the superior cervical ganglion of the cat. Brit. J. Pharmacol 12, 219-222
22. Simons TJB (1993). Lead-calcium interactions in cellular lead toxicity. Neurotoxicol 14, 77-86
23. Parr DR and Harris EJ (1976). The effect of lead on the calcium-handelling of rat heart mitochondria. Biochem J 158, 289-294
24. Chavez E, Jay D and Bravo C (1987). The mechanism of lead-induced mitochondrial calcium efflux. J Bioenegretics Biomembranes 19, 285-295
25. Goering PL (1993). Lead-protein interactions as a basis for lead toxicity. Neurotoxicol 14, 45-60
26. Regan CM (1989). Lead-impared neurodevelopment. Mechanisms and threshold values in the rodent. Neurotox Tetratol 11, 533-537
27. Murphy KJ, Fox GB, Kelly J and Regan CM (1995). Influence of toxicants on neural cell adhesion molecule-mediated neuroplasticity in the developing and adult animal: Persistent effects of chronic perinatal low-level lead exposure. Toxicology Letters 82-83, 271-276
28. Hayes FD and Breen KC (1994). Glucocorticoid potentiation of lead neurotoxicity in the mouse HN9 hippocampal cell line. Toxic in Vitro 8, 407-411
29. Lowry GH, Rosenbrough NL, Farr AL and Randall RJ (1951). Protein measurement with the folin reagent. J Biol Chem 193, 265-275
30. Martin ML, Breen KC and Regan CM (1988). Perturbations of cellular function integral to neural tube formation by the putative teratogen sodium valproate. Toxic in vitro 2, 43-48
31. Gillian AM, McFarlane I, Lucy FM, Overly CC, McConlogue L and Breen KC (1997). The individual isoforms of the amyloid β precursor protein demonstrate differential adhesive potentials to specific elements of the extracellular matrix. J Neurosci Res 49, 154-160
32. Saito F, Tani A, Miyatake T and Yanagisawa K (1995). N-linked oligosaccharide of beta-amyloid precursor protein (beta-APP) of C6 glioma cells - putative regulatory role In beta-APP processing. Biochem Biophys Res Comm 210, 703-710
33. Cookman GR, King W and Regan CM (1987). Chronic low-level lead exposure impairs embryonic to adult conversion of the neural cell adhesion molecule. J Neurochem 49, 399-403
34. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJS, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW, Stevens KA, Slunt HH, Sisodia SS, Chen HY and Van der Ploeg LHT (1995). β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531
35. Cosgaya JM, Latasa MJ and Pascual A (1996). Nerve growth factor and ras regulate β-amyloid precursor protein gene expression in PC12 cells. J Neurochem 67, 98-104
36. Nitsch RM, Deng MH, Growdon JH and Wurtman RJ (1996). Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem 271, 4188-4194
37. Bush AI, Multhaup G, Moir RD, Williamson TG, Small DH, Rumble B, Pollwein P, Beyreuther K and Masters CL (1993). A novel zinc(II) binding site modulates the function of the βA4 amyloid protein precursor of Alzheimer's disease. J Biol Chem 268, 16109-16112
38. Whyte S, Currie J, Maruff P, Malone V, Coulson EJ, Beyreuther K and Masters CL (1996). The effect of oral zinc supplementation on the amyloid precursor protein of Alzheimer's disease in human plasma and rat brain. Neurobiology of Aging 17, S82